Understanding Pain in IgA Kidney Disease
Part of Immune system & allergy, Kidney & urinary, Pain, Women’s health & pregnancy clinical trials.
This study looks at why some people with IgA nephropathy (a kidney disease confirmed by biopsy) experience episodes of loin pain (pain in the lower back/side area). Researchers want to understand what causes this pain to help develop better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with IgA nephropathy confirmed by a kidney biopsy
- You experience loin pain (lower back/side pain) at least once every 6 months, but not constantly
- You are not currently taking steroids or complement inhibitor medications
- You have not had a kidney transplant and are not on dialysis
- You can safely have an MRI scan (no incompatible metal implants like pacemakers)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study observes how people with IgA nephropathy respond to standard and newer treatments in everyday medical practice, to understand why some cases are resistant to therapy.
This trial tests an experimental tablet, HSK39297, for people with IgA nephropathy, a kidney disease. It aims to see if the drug is safe and can help reduce protein in the urine, which is a sign of kidney damage.
This study continues treatment with an experimental medicine called HSK39297 for people with IgA nephropathy, a condition where the immune system damages the kidneys. The trial will track how safe and effective the medicine is over time in people who already completed an earlier study.
This trial looks at how bacteria in the gut (microbiome) and substances in the body (metabonomics) relate to IgA nephropathy, a kidney condition. The goal is to understand patterns that may help explain the disease and improve future care.
This study looks at a specific type of antibody called IgA in patients with certain kidney diseases. It aims to understand which IgA antibodies cause kidney damage, which could help develop better treatments.
This study looks at how certain immune cells in blood relate to IgA nephropathy, a kidney condition. It may help doctors understand which patients are likely to do better and guide future care.
Hear when a new IgA Nephropathy (IgAN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.